These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28686225)

  • 1. Retrospective Proteomic Screening of 100 Breast Cancer Tissues.
    Pucci-Minafra I; Di Cara G; Musso R; Cancemi P; Albanese NN; Roz E; Minafra S
    Proteomes; 2017 Jul; 5(3):. PubMed ID: 28686225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
    Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
    J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
    Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
    Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation.
    Xu D; Aka JA; Wang R; Lin SX
    J Steroid Biochem Mol Biol; 2017 Jul; 171():270-280. PubMed ID: 28457968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential occurrence of S100A7 in breast cancer tissues: a proteomic-based investigation.
    Cancemi P; Di Cara G; Albanese NN; Costantini F; Marabeti MR; Musso R; Riili I; Lupo C; Roz E; Pucci-Minafra I
    Proteomics Clin Appl; 2012 Aug; 6(7-8):364-73. PubMed ID: 22641350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic patterns of cultured breast cancer cells and epithelial mammary cells.
    Pucci-Minafra I; Fontana S; Cancemi P; Alaimo G; Minafra S
    Ann N Y Acad Sci; 2002 Jun; 963():122-39. PubMed ID: 12095937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
    Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
    Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer: new technologies for risk assessment and diagnosis.
    Wright T; McGechan A
    Mol Diagn; 2003; 7(1):49-55. PubMed ID: 14529321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
    Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
    Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade.
    Fonseca-Sánchez MA; Rodríguez Cuevas S; Mendoza-Hernández G; Bautista-Piña V; Arechaga Ocampo E; Hidalgo Miranda A; Quintanar Jurado V; Marchat LA; Alvarez-Sánchez E; Pérez Plasencia C; López-Camarillo C
    Int J Oncol; 2012 Aug; 41(2):670-80. PubMed ID: 22614840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic characterization of early lung response to breast cancer metastasis in mice.
    Kurpińska A; Suraj J; Bonar E; Zakrzewska A; Stojak M; Sternak M; Jasztal A; Walczak M
    Exp Mol Pathol; 2019 Apr; 107():129-140. PubMed ID: 30763573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteome analysis of breast cancer and normal breast.
    Luo Y; Zhang J; Liu Y; Shaw AC; Wang X; Wu S; Zeng X; Chen J; Gao Y; Zheng D
    Mol Biotechnol; 2005 Mar; 29(3):233-44. PubMed ID: 15767701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study.
    Descotes F; Jézéquel P; Spyratos F; Campion L; Grenot C; Lerebours F; Campone M; Guérin-Charbonnel C; Lanoë D; Adams M; André J; Carlioz A; Martin PM; Chassevent A; Jourdan ML; Guette C; Zanella-Cleon I; Ricolleau G
    Int J Oncol; 2012 Jul; 41(1):92-104. PubMed ID: 22552268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling and interactome analysis of ER-positive/HER2/neu negative invasive ductal carcinoma of the breast: towards proteomics biomarkers.
    Korwar AM; Bhonsle HS; Ghole VS; Gawai KR; Koppikar CB; Kulkarni MJ
    OMICS; 2013 Jan; 17(1):27-40. PubMed ID: 23301641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA Mutational Status Is Associated with High Glycolytic Activity in ER+/HER2- Early Invasive Breast Cancer: a Molecular Imaging Study Using [
    Magometschnigg H; Pinker K; Helbich T; Brandstetter A; Rudas M; Nakuz T; Baltzer P; Wadsak W; Hacker M; Weber M; Dubsky P; Filipits M
    Mol Imaging Biol; 2019 Oct; 21(5):991-1002. PubMed ID: 30652258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells.
    Huang HJ; Lin CC; Chou HC; Chen YW; Lin ST; Lin YC; Lin DY; Lyu KW; Chan HL
    Mol Biosyst; 2014 Dec; 10(12):3086-100. PubMed ID: 25259860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.